ITGAL and psoriasis: Previous efforts targeting T cell trafficking in psoriasis included the use of efalizumab, which is a humanized monoclonal IgG1 antibody against CD11a, a subunit of lymphocyte function-associated antigen 1 (LFA-1) (9).